Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
Submitted by
admin
on May 31, 2018 - 9:40am
Source:
CP Wire
News Tags:
vTv Therapeutics
COPD
PDE4 inhibitors
Headline:
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
snippet:
Shares up over 47% in premarket trading
vTv will receive upfront payment and is eligible for future milestones and royalties
Partner intends to develop COPD treatment
Do Not Allow Advertisers to Use My Personal information
